Mohan Bala insider trades
Open-market stock purchases and sales by Mohan Bala, SVP, Chief Development at Mersana Therapeutics, Inc, from SEC Form 4 filings since Oct 25, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $56.3K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $124K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $400K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $571K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $160K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $795K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $89.8K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | $703K |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Jan 6, 2026 | MRSN Mersana Therapeutics, Inc | Sold (not open market) | — |
| Oct 27, 2025 | MRSN Mersana Therapeutics, Inc | Sold | $762 |
| Oct 25, 2025 | MRSN Mersana Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- MRSN Mersana Therapeutics, Inc: 8 sales, last Jan 6, 2026